Company news
Avecho Biotechnology Limited news in 2022
Avecho Biotechnology Limited's news releases, calls and decks from 2022, newest first.
Avecho receives ethics approval for Phase III CBD trial
December 21, 2022
AVE signs development agreement with Perrigo
December 19, 2022
September 2022 Quarterly Activities Report & Appendix 4C
October 27, 2022
Increased CBD absorption in dogs vs commercial comparator
September 19, 2022
June 2022 Quarterly Activities Report & Appendix 4C
July 28, 2022
Security Class Reinstatement to Quotation- AVEO
July 14, 2022
Update on Listed Options and Federal Court Application
July 14, 2022
Suspension from Official Quotation - AVEO
June 8, 2022
March 2022 Quarterly Activities Report & Appendix 4C
April 28, 2022
Positive results from AVEs topical CBD pain study
March 28, 2022
Dosing begins in topical CBD pain study
February 28, 2022
Appendix 4E and Annual Report 31 December 2021
February 27, 2022
AVE license agreement for US recreational cannabis market
February 2, 2022
December 2021 Quarterly Activities Report & Appendix 4C
January 30, 2022
Application for quotation of securities - AVE
January 9, 2022
Decks in 2022
- Shareholder Meeting (May 2022)
Shareholder meeting · 27 slides · May 30, 2022